The Future is Agentic: Unlocking AI’s Potential for Medical Insights
Discover how Agnetic is harnessing AI to revolutionize healthcare, unlocking powerful medical insights for better, faster, and more personalized care.
This author has not written his bio yet.
But we are proud to say that Jalene Kaiser contributed 155 entries already.
Discover how Agnetic is harnessing AI to revolutionize healthcare, unlocking powerful medical insights for better, faster, and more personalized care.
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
In today’s “Elevate” episode, our speaker panel, lead by Jennifer Riggins and Steve Casey of the MAPS Digital Strategy FAWG, dives into a topic at the cutting edge of medical information: the use of Generative AI for content creation.
This episode defines crisis management as a structured, cyclical process: preparedness, response, recovery, and reflection. We discuss how Medical Affairs plays a unique role in translating uncertainty into strategy, maintaining scientific clarity, and protecting external trust through transparent communication.
This episode defines crisis management as a structured, cyclical process: preparedness, response, recovery, and reflection. We discuss how Medical Affairs plays a unique role in translating uncertainty into strategy, maintaining scientific clarity, and protecting external trust through transparent communication.
This article is a summary of BGB Group’s 2025 Roundtable in London and outlines how Medical Affairs can lead digital transformation by leveraging AI and integrated tools, while addressing data, security, and adoption challenges to enhance strategic impact.
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
